Inventor · disambiguated record
Yangxin Fu
Also filed as: FU YANGXIN
6 granted patents·8 pending applications·1 citations·filing 2008–2025
66Inventor score
Files withSHANGHAI LONGYAO BIOTECHNOLOGY INC LTD6INST BIOPHYSICS CAS5DINGFU BIOTARGET CO LTD1FU YANGXIN1UNIV SHANGHAI JIAOTONG1
Top patents by PatentIndex Score
14 records- 0174US2025043008A1Fusion protein of interferon (ifn) and anti-pd-l1 antibody and use thereofINST BIOPHYSICS CAS·Filed 2024·Application pending·0 cites
- 0263US2025228935A1Construction and application of fusion protein vaccine platformINST BIOPHYSICS CAS·Filed 2025·Application pending·0 cites
- 0362US2023293679A1Construction and application of fusion protein vaccine platformINST BIOPHYSICS CAS·Filed 2021·Application pending·0 cites
- 0462US2025223329A1Bifunctional fusion protein composed of il-15 and antibody against t cell co-stimulatory moleculeINST BIOPHYSICS CAS·Filed 2024·Application pending·0 cites
- 0561US12077589B2Fusion protein of interferon (IFN) and anti-PD-L1 antibody and use thereofINST BIOPHYSICS CAS·Filed 2019·Granted Sep 3, 2024·0 cites·11 claims
- 0655US8263823B2Immunocompetent xenograft modelFU YANGXIN·Filed 2008·Granted Sep 11, 2012·1 cites·16 claims
- 0754US2023134345A1Chimeric antigen receptor comprising third signal receptor and use thereofSHANGHAI LONGYAO BIOTECHNOLOGY INC LTD·Filed 2022·Application pending·0 cites
- 0853US12359169B2Universal CAR-T cell and preparation method and use thereofSHANGHAI LONGYAO BIOTECHNOLOGY INC LTD·Filed 2022·Granted Jul 15, 2025·0 cites·5 claims
- 0952US2023277666A1Chimeric antigen receptor comprising co-stimulatory receptor and application thereofSHANGHAI LONGYAO BIOTECHNOLOGY INC LTD·Filed 2023·Application pending·0 cites
- 1047US11524034B2Chimeric antigen receptor comprising third signal receptor and use thereofSHANGHAI LONGYAO BIOTECHNOLOGY INC LTD·Filed 2020·Granted Dec 13, 2022·0 cites·6 claims
- 1145US11590168B2Chimeric antigen receptor comprising co-stimulatory receptor and application thereofSHANGHAI LONGYAO BIOTECHNOLOGY INC LTD·Filed 2020·Granted Feb 28, 2023·0 cites·7 claims
- 1245US2021108175A1Universal car-t cell and preparation method and use thereofSHANGHAI LONGYAO BIOTECHNOLOGY INC LTD·Filed 2020·Application pending·0 cites
- 1342US12448446B2Chimeric antigen receptor and use thereofUNIV SHANGHAI JIAOTONG·Filed 2020·Granted Oct 21, 2025·0 cites·18 claims
- 1435US2015344577A1Agents for treating tumors, use and method thereofDINGFU BIOTARGET CO LTD·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yangxin Fu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →